Mike Kujak
President and CEO

Mike joins Francis Medical with more than 30 years of broad healthcare marketing and sales leadership experiences in medical devices, pharmaceutical, biotechnology, clinical research and payer economics. Prior to joining Francis Medical, Mike was the Chief Marketing Officer and Senior Vice President of International for NxThera.  Prior to NxThera he was the Vice President and General Manager of the Prostate Health business unit of American Medical Systems, which developed and commercialized medical device solutions to treat BPH, prostate cancer and stone disease. Mike received his MBA from the OPUS College of Business, University of St. Thomas in St. Paul Minnesota and a Bachelor of Science in physics and chemistry from the University of South Dakota.

Michael Hoey
Founder & Chief Technology Officer

Michael co-founded NxThera in 2008 to develop and commercialize the urology applications of the vapor platform technology that he invented. Michael has been a director and chief technology officer since NxThera’s inception. Prior to becoming an entrepreneur, Michael taught in several departments and performed research at the University of Minnesota, including the Department of Physiology, the Department of Urologic Surgery in the School of Medicine, the Institute of Technology, and the Carlson School of Management. Professor Hoey also taught in the department of Biological Sciences at Hamline University in St. Paul, Minnesota. Michael is an expert in the interaction of thermotherapy and tissue and a prolific inventor, with 72 patents granted and 94 patents pending, the majority of which are in the medical device field. Michael’s inventions include platform technologies, which are the foundation for products being sold, or in development for a variety of cardiac surgery, oncology, orthopaedics, pulmonology, general surgery, urology, gynecology, and vascular surgery applications. Michael has been a consultant to, as well as a founder/principal of, several medical products companies, which combined have raised over $250 million of capital.

Kristine Selander
Vice President, Clinical Affairs

Kris joined Francis Medical in August of 2018 with 20 years of global experience in clinical research and clinical operations. She has led the design and execution of numerous device clinical studies from early feasibility to post-market in multiple therapeutic areas. Prior to joining Francis Medical, Kris led the clinical team at Inspire Medical Systems, and has also held leadership positions at Nevro, Medtronic and American Medical Systems. Kris holds a B.S. in Biology from the College of St. Catherine, and an M.S. in Nutrition from the University of Minnesota.

André de Bruin
Chairman

Mr. de Bruin joined the NxThera board of directors in 2009 with more than 35 years of global healthcare industry experience spanning the bio-pharmaceutical, medical device and in-vitro diagnostics markets. Prior to his retirement in 2004 as executive chairman of Quidel Corporation’s board of directors, André served as the company’s chief executive officer from 1998 until 2001. He was chairman, president and chief executive officer of Somatogen, a bio-pharmaceuticals company, prior to its acquisition by Baxter. Before joining Somatogen, André was chairman, president and chief executive officer of Boehringer Mannheim Corporation, a global healthcare company subsequently acquired by Hoffman-La Roche. Past experience includes advisory services for Ferrer, Freeman and Company LLC and various boards of directors. Most recently André was a board member of Nanosphere Inc., a public company in Northbrook, IL, engaged in the field of developing and commercializing molecular diagnostics for nucleic acid detection of infectious diseases. André received a B.S. in finance, economics and business from the University of Potchefstroom in South Africa.

Jan Garfinkle
Founder & Managing Director, Arboretum Ventures

Jan Garfinkle founded Arboretum Ventures in 2002 and is a Managing Director. At Arboretum, Jan focuses on promising medical technologies that enable meaningful healthcare system savings. Jan has led more than a dozen investments and currently serves as a board director for NxThera, Cereve, NeuMoDx, and Cardiac Dimensions. Jan’s past investments include HandyLab (acquired by Becton Dickinson in 2009 for $275 million), Esperion (IPO in 2013), and CardioMEMS (acquired by St. Jude Medical in 2014 for $435 million). Prior to founding Arboretum, Jan spent 20 years in entrepreneurial healthcare companies. She was President of Strategic Marketing Consultants, advising healthcare start-ups and major medical device companies. Prior to this, Jan held key management roles for two successful medical device start-ups, Advanced Cardiovascular Systems and Devices for Vascular Intervention. Each of these companies was acquired by Eli Lilly for more than $100 million and became the foundation for Guidant Corporation. Earlier in her career, Jan was an engineer and product manager for Procter & Gamble. Jan is the past President of the Michigan Venture Capital Association, a member of the Board of Directors for the National Venture Capital Association, and a member of the Healthcare Advisory Board at the University of Michigan. Jan earned a B.S. in Bioengineering from the University of California at Berkeley and an M.B.A. from the Wharton School at the University of Pennsylvania.

David Adair MD
Director – Solas BioVentures

Dave has worked with the partners of Solas BioVentures Fund since 2004 and was a founding member of the fund in 2014. He currently focuses on investments in medical device and therapeutic companies. Board certified in Maternal-Fetal Medicine, Obstetrics and Gynecology, and Hypertension, with special expertise in Critical Care, Dave is a long-time physician, educator, administrator, innovator, and biotech/med-tech investor with nearly 20 years of experience in angel and venture investing. Dave currently serves as Professor and Vice Chairman of the Department of Obstetrics and Gynecology at the University of Tennessee College of Medicine. He is an active candidate for his MBA in Healthcare at the University of Tennessee Chattanooga. Dave received a BS in Biology from Morehead State University, where he is Hall of Fame member and earned his medical degree from the Joan C. Edwards College of Medicine at Marshall University in 1990. He completed residency at the University of Florida Health Science Center and Fellowship training at Wake Forest University.
Besides serving on the board at Francis Medical, Dave serves as a director for Arrivo Bio Ventures, Aegea Medical, Advanced Catheter Therapies, PreTel Health, Velo Bio, and Anogen Life Sciences. Dave and his colleagues have invested in many cutting edge and disruptive medical device and biotech companies, including Veran Medical Technologies (where he served previously as a board director), Addrenex (acquired by Sciele/Shionogi), Neuronex (acquired by Acorda), Velo Bio (acquired by AMAG Pharmaceuticals), Aerial Bio (acquired by Jazz Pharmaceuticals), and NxThera (acquired by Boston Scientific). Dave also founded Glenveigh Pharmaceuticals, which had products out-licensed to Protherics and acquired by Clinical Innovations.

Mike Kujak
CEO Francis Medical

Mike joins Francis Medical with more than 30 years of broad healthcare marketing and sales leadership experiences in medical devices, pharmaceutical, biotechnology, clinical research and payer economics. Prior to joining Francis Medical, Mike was the Chief Marketing Officer and Senior Vice President of International for NxThera. Prior to NxThera he was the Vice President and General Manager of the Prostate Health business unit of American Medical Systems, which developed and commercialized medical device solutions to treat BPH, prostate cancer and stone disease. Mike received his MBA from the OPUS College of Business, University of St. Thomas in St. Paul Minnesota and a Bachelor of Science in physics and chemistry from the University of South Dakota.

Michael Hoey
Founder & Chief Technology Officer

Michael co-founded NxThera in 2008 to develop and commercialize the urology applications of the vapor platform technology that he invented. Michael has been a director and chief technology officer since NxThera’s inception. Prior to becoming an entrepreneur, Michael taught in several departments and performed research at the University of Minnesota, including the Department of Physiology, the Department of Urologic Surgery in the School of Medicine, the Institute of Technology, and the Carlson School of Management. Professor Hoey also taught in the department of Biological Sciences at Hamline University in St. Paul, Minnesota. Michael is an expert in the interaction of thermotherapy and tissue and a prolific inventor, with 72 patents granted and 94 patents pending, the majority of which are in the medical device field. Michael’s inventions include platform technologies, which are the foundation for products being sold, or in development for a variety of cardiac surgery, oncology, orthopaedics, pulmonology, general surgery, urology, gynecology, and vascular surgery applications. Michael has been a consultant to, as well as a founder/principal of, several medical products companies, which combined have raised over $250 million of capital.

December 13th, 2018

Francis Medical, Inc., a Minneapolis-based, privately held medical device company developing an innovative and proprietary vapor ablation therapy to treat a variety of endourology cancers, beginning with Prostate Cancer (PCa), today announced the completion of a $18.0 million round of Series A financing.

December 17th, 2018

Francis Medical, Inc. was featured in BioWorld MedTech, a leading news source of advances in medical technology.